Thomas Eisele
Professor & Director, Center for Applied Malaria Research and Evaluation
Areas of Expertise
Biography
Thom Eisele is a professor in the department of tropical medicine in the Tulane School of Public Health and Tropical Medicine, and the director of the Center for Applied Malaria Research and Evaluation. His research focuses on malaria epidemiology and evaluating malaria control and elimination strategies. Areas of expertise include malaria epidemiology, evaluating the impact of malaria control/elimination strategies, and measurement of malaria intervention coverage and malaria health outcomes. His current research focuses on measuring the impact of malaria elimination strategies, including mass drug administration, in Zambia and Haiti with funding from the Bill & Melinda Gates Foundation. Dr. Eisele is a member of the Roll Back Malaria Monitoring and Evaluation Reference Group, and was previously a member of the Technical Expert Group on Surveillance, Monitoring and Evaluation for the WHO Global Malaria Program, and a Malaria Expert Group member of the WHO Child Health Epidemiology Reference Group.
Education
Tulane University
Tulane University
University of Texas, Austin
Links
Articles
Assessing the role of the private sector in surveillance for malaria elimination in Haiti and the Dominican Republic: a qualitative study
2019
Haiti and the Dominican Republic (DR) are targeting malaria elimination by 2022. The private health sector has been relatively unengaged in these efforts, even though most primary health care in Haiti is provided by non-state actors, and many people use traditional medicine. Data on private health sector participation in malaria elimination efforts are lacking, as are data on care-seeking behaviour of patients in the private health sector.
Mass drug administration can be a valuable addition to the malaria elimination toolbox
2019
The Global Technical Strategy 2016–2030 of the World Health Organization (WHO) has the ambitious goal of malaria being eliminated from at least 35 countries by 2030. However, in areas with once-stable malaria transmission, the reservoir of human infection may be intermittently symptomatic or fully silent yet still lead to transmission, posing a serious challenge to elimination.
High-throughput malaria serosurveillance using a one-step multiplex bead assay
2019
Serological data indicating the presence and level of antibodies against infectious disease antigens provides indicators of exposure and transmission patterns in a population. Laboratory testing for large-scale serosurveys is often hindered by time-consuming immunoassays that employ multiple tandem steps.
